Cura is bootstrapped. There are three of us and a contractor, and I funded the business out of my own bank account and the deals we close. No venture round. No board asking us to triple ARR by next year.
I want to tell you why, because it changes what Cura is and how it's priced.
I built Cura because I hated the reporting grind
Before Cura, I was on the other side of the table — reporting to my own investors and chasing my portfolio founders for updates. I'd send the ask, get a reply three weeks later, and end up filling out reports late at night. I went through that pain for years. About a year and a half ago I started building Cura to end it.
The first version tried to automate back-office workflows with agents. It failed 20 to 30 percent of the time, and the reason was always the same: the agent was missing context. So I changed the goal. Get as close to 100 percent context capture as possible — the board decks, the emails, the WhatsApp threads, the Slack updates, the Granola calls, the public signal — all the portfolio information that otherwise gets lost in the ether. Give agents deep context, and they stop failing.
Bootstrapped was a choice, not a fallback
I could have raised. I didn't want to.
I wanted to work closely with a smaller group of customers, treat them well, and price fairly — without the grow-at-all-costs pressure that comes with a venture round. There isn't a venture-scale outcome here anyway. Run a lean ship, go AI-native across the board, and a team of three can do a lot of damage.
That shows up in the numbers. We have tiny operating expenses. Our costs are mostly AI, not headcount. So we can charge a fraction of what the incumbents charge and still build a better product. When we win head-to-head deals, price is often why we get in the door — and the product is why we stay.
What it means for your pricing
As a software buyer myself, I hate variable costs. I want a predictable line item I can plan around, not a bill that balloons with usage. So Cura starts at $200/month on the Emerging Manager plan, and 90% of customers pay $5,000 to $15,000 a year. It is consistently one of the most affordable options in the category. The pricing section shows the current plans.
Low cost also lets us serve people the incumbents ignore. There's a long tail of emerging managers who could never justify a $50,000 or $60,000 contract because their AUM isn't there yet. Those funds deserve institutional-quality reporting too. Being small and bootstrapped is what lets us serve them.
It's also a trust story
When you're bootstrapped, your customers are the only people you answer to. Your data isn't a growth lever we sell to a competitor or feed into a shared model. We don't have an investor pushing us toward the moves that would make that tempting. A few funds have told me the bootstrapped story is the part they trust most, and I understand why.
If that's the kind of company you'd rather buy from, book a demo and I'll load your portfolio into Cura myself. And if you're weighing us against the incumbents, the honest Cura vs Standard Metrics breakdown is a good place to start.